T E Romer

470 total citations
22 papers, 366 citations indexed

About

T E Romer is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Genetics. According to data from OpenAlex, T E Romer has authored 22 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Molecular Biology and 6 papers in Genetics. Recurrent topics in T E Romer's work include Growth Hormone and Insulin-like Growth Factors (9 papers), Sexual Differentiation and Disorders (9 papers) and Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (4 papers). T E Romer is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (9 papers), Sexual Differentiation and Disorders (9 papers) and Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (4 papers). T E Romer collaborates with scholars based in Poland, Germany and France. T E Romer's co-authors include Krzysztof Kula, Mieczysław Walczak, Jolanta Słowikowska‐Hilczer, Maria Szarras‐Czapnik, Paul Saenger, Serge Lumbroso, F Péter, E Małunowicz, P Garandeau and Charles Sultan and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Journal of Histochemistry & Cytochemistry and Clinical Endocrinology.

In The Last Decade

T E Romer

22 papers receiving 354 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T E Romer Poland 12 202 170 107 60 57 22 366
Margaret E. Bock Canada 11 291 1.4× 171 1.0× 200 1.9× 70 1.2× 48 0.8× 18 533
A. M. Comaru-Schally United States 10 113 0.6× 260 1.5× 119 1.1× 33 0.6× 28 0.5× 12 662
Ke-ita Tatsumi Japan 13 179 0.9× 385 2.3× 131 1.2× 33 0.6× 29 0.5× 19 505
G.H. Donker Netherlands 14 116 0.6× 191 1.1× 319 3.0× 22 0.4× 29 0.5× 27 514
Chiaoyun Benson Kuo United States 8 147 0.7× 185 1.1× 80 0.7× 16 0.3× 12 0.2× 10 345
Masatomo Kusaka Japan 9 300 1.5× 40 0.2× 338 3.2× 58 1.0× 22 0.4× 9 428
Anna Kruglikova Russia 9 108 0.5× 40 0.2× 131 1.2× 26 0.4× 15 0.3× 28 327
Maria Kalina Poland 9 174 0.9× 113 0.7× 90 0.8× 37 0.6× 37 0.6× 26 370
C Lecointre France 10 336 1.7× 155 0.9× 203 1.9× 36 0.6× 55 1.0× 15 506
Stephanie Beall United States 11 150 0.7× 34 0.2× 53 0.5× 77 1.3× 24 0.4× 15 460

Countries citing papers authored by T E Romer

Since Specialization
Citations

This map shows the geographic impact of T E Romer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T E Romer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T E Romer more than expected).

Fields of papers citing papers by T E Romer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T E Romer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T E Romer. The network helps show where T E Romer may publish in the future.

Co-authorship network of co-authors of T E Romer

This figure shows the co-authorship network connecting the top 25 collaborators of T E Romer. A scholar is included among the top collaborators of T E Romer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T E Romer. T E Romer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Romer, T E, et al.. (2017). A follow-up history of young man with apparent cortisone reductase deficiency (ACRD) – several years after diagnosis. Pediatric Endocrinology Diabetes and Metabolism. 23(1). 42–48. 1 indexed citations
2.
Kriström, Berit, et al.. (2017). Ten years of clinical experience with biosimilar human growth hormone: a review of safety data. Drug Design Development and Therapy. Volume 11. 1497–1503. 15 indexed citations
3.
Romer, T E, et al.. (2011). Effect of switching recombinant human growth hormone: Comparative analysis of phase 3 clinical data. PubMed. 1(1). 5–5. 14 indexed citations
4.
5.
Peterkova, Valentina, İlknur Arslanoğlu, T E Romer, et al.. (2007). A Randomized, Double-Blind Study to Assess the Efficacy and Safety of Valtropin, a Biosimilar Growth Hormone, in Children with Growth Hormone Deficiency. Hormone Research in Paediatrics. 68(6). 288–293. 24 indexed citations
6.
Romer, T E, F Péter, Paul Saenger, et al.. (2007). Efficacy and safety of a new ready-to-use recombinant human growth hormone solution. Journal of Endocrinological Investigation. 30(7). 578–589. 41 indexed citations
7.
Pańkowska, Ewa, Mieczysław Szalecki, & T E Romer. (2007). [Metabolic control and insulin administration in a girl with Turner syndrome and type 1 diabetes during long-term growth hormone therapy].. PubMed. 13(4). 213–5. 3 indexed citations
8.
Słowikowska‐Hilczer, Jolanta, T E Romer, & Krzysztof Kula. (2003). Neoplastic Potential of Germ Cells in Relation to Disturbances of Gonadal Organogenesis and Changes in Karyotype. Journal of Andrology. 24(2). 270–278. 44 indexed citations
9.
Małunowicz, E, T E Romer, Maria D. Urban, & Artur Bossowski. (2003). 11β-Hydroxysteroid Dehydrogenase Type 1 Deficiency (‘Apparent Cortisone Reductase Deficiency’) in a 6-Year-Old Boy. Hormone Research in Paediatrics. 59(4). 205–210. 20 indexed citations
10.
Martens, John W.M., Serge Lumbroso, Miriam Verhoef‐Post, et al.. (2002). Mutant Luteinizing Hormone Receptors in a Compound Heterozygous Patient with Complete Leydig Cell Hypoplasia: Abnormal Processing Causes Signaling Deficiency. The Journal of Clinical Endocrinology & Metabolism. 87(6). 2506–2513. 49 indexed citations
11.
Romer, T E, Martin O. Savage, B Woźniewicz, et al.. (1998). Luteinizing hormone secreting adrenal tumour as a cause of precocious puberty. Clinical Endocrinology. 48(3). 367–372. 6 indexed citations
12.
Małunowicz, E, Maria Ginalska-Malinowska, T E Romer, & Karol Bal. (1998). The influence of prenatal dexamethasone treatment on urinary excretion of adrenocortical steroids in newborns. European Journal of Pediatrics. 157(7). 539–543. 6 indexed citations
13.
14.
15.
Romer, T E, et al.. (1996). [Levels of the CASA tumor marker during the menstrual cycle].. PubMed. 118(7). 412–3. 1 indexed citations
16.
Lumbroso, Serge, J M Lobaccaro, Maria Szarras‐Czapnik, et al.. (1995). Molecular study of the 5 alpha-reductase type 2 gene in three European families with 5 alpha-reductase deficiency.. The Journal of Clinical Endocrinology & Metabolism. 80(7). 2149–2153. 45 indexed citations
17.
Romer, T E, et al.. (1995). Heterogeneity of Urinary Steroid Profiles in Children with Adrenocortical Tumors. Hormone Research. 44(4). 182–188. 11 indexed citations
18.
Milewicz, Andrzej, et al.. (1993). Evaluation of 21-deoxycortisol as a marker for the detection of heterozygous carriers of 21-hydroxylase deficiency.. PubMed. 44(2). 187–93. 4 indexed citations
19.
Romer, T E, et al.. (1981). [Silver-Russell syndrome--one of the forms of intrauterine growth inhibition described on the basis of our personal cases and literature review].. PubMed. 32(2). 137–52. 1 indexed citations
20.
Romer, T E. (1964). CORTICOSTEROIDS IN BROWN FAT BY A HISTOCHEMICAL METHOD. Journal of Histochemistry & Cytochemistry. 12(8). 646–646. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Margaret E. Bock Breakdown of academic impact, for papers by A. M. Comaru-Schally Breakdown of academic impact, for papers by Ke-ita Tatsumi Breakdown of academic impact, for papers by G.H. Donker Breakdown of academic impact, for papers by Chiaoyun Benson Kuo Breakdown of academic impact, for papers by Masatomo Kusaka Breakdown of academic impact, for papers by Anna Kruglikova Breakdown of academic impact, for papers by Maria Kalina Breakdown of academic impact, for papers by C Lecointre Breakdown of academic impact, for papers by Stephanie Beall
Rankless by CCL
2026